Financial Calendar

Past Events

Oct 8, 2026

Q3 2026 Cash Position

Sep 29, 2026

H1 2026 Financial Statement

Jul 8, 2026

Q2 2026 Cash position

May 19, 2026

Annual General Meeting

Upcoming Events

Jan 6, 2027

Cash Position as of December 31, 2026

Mar 30, 2027

Full-year 2026 Results

Apr 7, 2027

Cash Position as of March 31, 2027

May 19, 2027

Annual General Meeting

Stock Information

GenSight Biologics

—
—
—
Stock prices are delayed by 15 minutes.

FR0013183985

SIGHT

Euronext Paris

Analyst Coverage

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France